Crohn's Disease

9 competing products in clinical development for Crohn's Disease.

Pipeline by Phase

Phase 12

Phase 1/21

Phase 22

Phase 2/32

Phase 32

All Products (9)

Product	Company	Stage	Status	Hype
CT-P13 + Remicade	Celltrion	Phase 3	Completed	40
CT-P13 SC (Infliximab)	Celltrion	Phase 3	Completed	40
adalimumab + adalimumab + placebo	Eisai	Phase 2/3	Completed	38
adalimumab	Eisai	Phase 2/3	Completed	38
CP-461	Astellas Pharma	Phase 2	Completed	35
E6011 + Placebo	Eisai	Phase 2	Completed	35
E6011 2 mg/kg + E6011 5 mg/kg + E6011 10 mg/kg + E6011 15 mg/kg	Eisai	Phase 1/2	Completed	32
CT-P13 + CT-P13 + CT-P13 + CT-P13 + CT-P13 + CT-P13	Celltrion	Phase 1	Completed	29
E6011 + Placebo	Eisai	Phase 1	Withdrawn	21